Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig H Moskowitz

Showing results (31-40 of 143) with videos related to

Pageof 15
Sort By:
British Journal of Haematology|February 12, 2004
Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's diseaseCraig H Moskowitz, Tarun Kewalramani, Stephen D Nimer, et al.
Leukemia Research|May 28, 2013
Tumor associated macrophages in relapsed and refractory Hodgkin lymphomaCarla Casulo, Maria Arcila, Olga L Bohn, et al.
British Journal of Haematology|October 13, 2015
Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B-cell lymphoma in the rituximab eraAnita Kumar, Matthew A Lunning, Zhigang Zhang, et al.
American Journal of Hematology|August 28, 2022
A roadmap for clinical trial design in marginal zone lymphomaJuan Pablo Alderuccio, Thomas Habermann, Russ Kuker, et al.
Blood|August 25, 2010
Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphomaAlison J Moskowitz, Joachim Yahalom, Tarun Kewalramani, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 13, 2010
The role of cytotoxic and regulatory T cells in relapsed/refractory Hodgkin lymphomaAashiyana F Koreishi, Adam J Saenz, Dan O Persky, et al.
JCO Clinical Cancer Informatics|July 16, 2025
Deep Learning-Based Body Composition Analysis for Outcome Prediction in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Insights From the LOTIS-2 TrialRuss A Kuker, Juan P Alderuccio, Sunwoo Han, et al.
British Journal of Haematology|June 9, 2006
Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphomaTarun Kewalramani, Andrew D Zelenetz, Julie Teruya-Feldstein, et al.
Cancers|November 11, 2022
A Deep Learning-Aided Automated Method for Calculating Metabolic Tumor Volume in Diffuse Large B-Cell LymphomaRuss A Kuker, David Lehmkuhl, Deukwoo Kwon, et al.
Leukemia & Lymphoma|April 22, 2014
Autologous stem cell transplant in recurrent or refractory primary or secondary central nervous system lymphoma using thiotepa, busulfan and cyclophosphamideMary R Welch, Craig S Sauter, Matthew J Matasar, et al.
Pageof 15

Showing results (31-40 of 143) with videos related to

Sort By:
Pageof 15
British Journal of Haematology|February 12, 2004
Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's diseaseCraig H Moskowitz, Tarun Kewalramani, Stephen D Nimer, et al.
Leukemia Research|May 28, 2013
Tumor associated macrophages in relapsed and refractory Hodgkin lymphomaCarla Casulo, Maria Arcila, Olga L Bohn, et al.
British Journal of Haematology|October 13, 2015
Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B-cell lymphoma in the rituximab eraAnita Kumar, Matthew A Lunning, Zhigang Zhang, et al.
American Journal of Hematology|August 28, 2022
A roadmap for clinical trial design in marginal zone lymphomaJuan Pablo Alderuccio, Thomas Habermann, Russ Kuker, et al.
Blood|August 25, 2010
Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphomaAlison J Moskowitz, Joachim Yahalom, Tarun Kewalramani, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 13, 2010
The role of cytotoxic and regulatory T cells in relapsed/refractory Hodgkin lymphomaAashiyana F Koreishi, Adam J Saenz, Dan O Persky, et al.
JCO Clinical Cancer Informatics|July 16, 2025
Deep Learning-Based Body Composition Analysis for Outcome Prediction in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Insights From the LOTIS-2 TrialRuss A Kuker, Juan P Alderuccio, Sunwoo Han, et al.
British Journal of Haematology|June 9, 2006
Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphomaTarun Kewalramani, Andrew D Zelenetz, Julie Teruya-Feldstein, et al.
Cancers|November 11, 2022
A Deep Learning-Aided Automated Method for Calculating Metabolic Tumor Volume in Diffuse Large B-Cell LymphomaRuss A Kuker, David Lehmkuhl, Deukwoo Kwon, et al.
Leukemia & Lymphoma|April 22, 2014
Autologous stem cell transplant in recurrent or refractory primary or secondary central nervous system lymphoma using thiotepa, busulfan and cyclophosphamideMary R Welch, Craig S Sauter, Matthew J Matasar, et al.
Pageof 15